✦ LIBER ✦

A Randomized Withdrawal, Placebo-Controlled Study Evaluating the Efficacy and Tolerability of Tapentadol Extended Release in Patients With Chronic Painful Diabetic Peripheral Neuropathy

✍ Scribed by Vinik, Aaron I.; Shapiro, Douglas Y.; Rauschkolb, Christine; Lange, Bernd; Karcher, Keith; Pennett, Deborah; Etropolski, Mila S.

Book ID: 121868816
Publisher: American Diabetes Association
Year: 2014
Tongue: English
Weight: 878 KB
Volume: 37
Category: Article
ISSN: 0149-5992
DOI: 10.2337/dc13-2291

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and tolerability of tapentadol

Efficacy and tolerability of tapentadol extended release (ER) in patients with chronic, painful diabetic peripheral neuropathy (DPN): results of a phase 3, randomized-withdrawal, placebo-controlled study

✍ A. Vinik; D. Shapiro; C. Rauschkolb-Löffler; B. Lange; K. Karcher; D. Pennett; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 38 KB

Safety and efficacy of tapentadol ER in

Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial

✍ Schwartz, Sherwyn; Etropolski, Mila; Shapiro, Douglas Y.; Okamoto, Akiko; Lange, 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 364 KB

Sensitivity analyses of the primary effi

Sensitivity analyses of the primary efficacy endpoint in a randomized-withdrawal phase 3 trial of tapentadol extended release (ER) in patients with painful diabetic peripheral neuropathy (DPN)

✍ Etropolski, M.; Steup, A.; Shapiro, D.Y.; Okamoto, A.; Haeussler, J. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 448 KB

Analgesic efficacy of fulranumab in pati

Analgesic efficacy of fulranumab in patients with painful diabetic peripheral neuropathy in a randomized, placebo-controlled, double-blind study

✍ Wang, H.; Romano, G.; Frustaci, M.E.; Sanga, P.; Ness, S.; Russell, L.J.; Fedgch 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 79 KB

Health status (EuroQol-5 Dimension [EQ-5

Health status (EuroQol-5 Dimension [EQ-5D]) in patients with painful diabetic peripheral neuropathy (DPN) treated with tapentadol extended release (ER): results of a randomized-withdrawal phase 3 study

✍ Okamoto, A.; Shapiro, D.Y.; Lange, B.; Lange, R.; Etropolski, M. 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 435 KB

Health-related outcomes associated with

✍ Etropolski, M.; Kleinert, R.; Shapiro, D.Y.; Okamoto, A.; Lange, R.; Rauschkolb, 📂 Article 📅 2009 🏛 Canadian Diabetes Association 🌐 English ⚖ 436 KB